Macrophage colony-stimulating factor (M-CSF) augments cytokine induction by lipopolysaccharide (LPS)-stimulation and by bacterial infections in mice

Immunopharmacology

Volumn 37, Issue 1, 1997, Pages 15-23

  Hanamura, Takuji ^a   Asakura, Eiji ^a   Tanabe, Toshizumi ^a  

^a Green Cross Company   (South Korea)

Author keywords

Lipopolysaccharide; Macrophage colony stimulation factor; Monokine; Priming

Indexed keywords

CYTOKINE; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 1ALPHA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; RECOMBINANT COLONY STIMULATING FACTOR 1; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ARTICLE; BACTERIAL INFECTION; BLOOD LEVEL; CONTROLLED STUDY; DOSE RESPONSE; DOSE TIME EFFECT RELATION; ESCHERICHIA COLI; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HOST RESISTANCE; INTRAVENOUS DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; T LYMPHOCYTE;

ANIMALS; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; ESCHERICHIA COLI INFECTIONS; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; INTERFERON TYPE II; INTERLEUKIN-1; INTERLEUKIN-10; INTERLEUKIN-6; KINETICS; LIPOPOLYSACCHARIDES; MALE; MICE; MICE, INBRED STRAINS; MICE, NUDE; STAPHYLOCOCCAL INFECTIONS; STIMULATION, CHEMICAL; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0030852775     PISSN: 01623109     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0162-3109(96)00166-X     Document Type: Article

References (41)

1. Asakura E, Hanamura T, Umemura A, Yada K, Yamauchi T, Tanabe T. Effects of macrophage colony-stimulating factor (M-CSF) on lipopolysaccharide (LPS)-induced mediator production from monocytes in vitro. Immunobiology 1996; 195: 300-313.
2. Bermudez LEM, Young LS. Tumor necrosis factor, alone or in combination with IL-2, but not IFN-γ, is associated with macrophage killing of Mycobacterium avium complex. J Immunol 1988; 140: 3006-3013.
3. Black CM, Catterall JR, Remington JS. In vivo and in vitro activation of alveolar macrophages by recombinant interferon-γ. J Immunol 1987; 138: 491-495.
4. Cenci E, Bartocci A, Puccetti P, Mocci S, Stanley ER, Bistoni F. Macrophage colony-stimulating factor in murine candidiasis: Serum and tissue levels during infection and protective effect of exogenous administration. Infect Immun 1991; 59: 868-872.
5. Clark SC, Kamen R. The human hematopoietic colony-stimulating factors. Science 1987; 236: 1229-1237.
6. Cockfield SM, Ramassar V, Halloran PF. Regulation of IFN-γ and tumor necrosis factor-α expression in vivo. J Immunol 1993; 150: 342-352.
7. Czuprynski CJ, Brown JF, Young KM, Cooley AJ, Kurtz RS. Effects of murine recombinant interleukin la on the host response to bacterial infection. J Immunol 1988; 140: 962-968.
8. Desiderio JV, Kiener PA, Lin P-F, Warr GA. Protection of mice against Listeria monocytogenes infection by recombinant human tumor necrosis factor alpha. Infect Immun 1989; 57: 1615-1617.
9. Evans R, Kamdar SJ, Duffy TM, Fuller J. Synergistic interaction of bacterial lipopolysaccharide and the monocyte-macrophage colony-stimulating factor: Potential quantitative and qualitative changes in macrophage-produced cytokine bioactivity. J Leukocyte Biol 1992; 51: 93-96.
10. Fujita H, Masuda H, Nakajima T, Nakae T, Narita Y, Yada K, Watanebe M, Kagitani Y. Protective effect of human macrophage colony-stimulating factor (hM-CSF) on fungal infection (1) In vivo effect of hM-CSF on systemic candidiasis and in vitro effect of hM-CSF on macrophages activities. J Jpn Assoc Infect Dis 1995; 69: 60-67.
11. Gray PW. Interferon-γ. In: BB Aggarwal, JU Gutterman, Eds. Human Cytokinens. Boston: Blackwell Scientific Publications, 1992; 30-45.
12. Gregory SH, Wing EJ, Tweardy DJ, Shadduck RK, Lin HS. Primary listerial infections are exacerbated in mice administered neutralizing antibody to macrophage colony-stimulating factor. J Immunol 1992; 149: 188-193.
13. Ho RJY, Chong KT, Merigan TC. Antiviral activity and dose optimum of recombinant macrophage colony-stimulating factor on herpes simplex genitalis in guinea pigs. J Immunol 1991; 146: 3578-3582.
14. Karbassi A, Becker JM, Foster JS, Moore RN. Enhanced killing of Candida albicans by murine macrophages treated with macrophage colony-stimulating factor: Evidence for augmented expression of mannose receptors. J Immunol 1987; 139: 417-421.
15. Kayashima S, Tsuru S, Shinomiya N, Katsura Y, Motoyoshi K, Rokutanda M, Nagata N. Effects of macrophage colony-stimulating factor on reduction of viable bacteria and survival of mice during Listeria monocytogenes infection: Characteristics of monocyte subpopulations. Infect Immun 1991; 59: 4677-4680.
16. Kiderlen AF, Kaufmann SHE, Lohmann-Matthes M-L. Protection of mice against the intracellular bacterium Listeria monocytogenes by recombinant immune interferon. Eur J Immunol 1984; 14: 964-967.
17. Kurtz RS, Young KM, Czuprynski CJ. Separate and combined effects of recombinant interleukin-1α and gamma interferon on antibacterial resistance. Infect Immun 1989; 57: 553-558.
18. Ladner MB, Martin GA, Noble JA. Human CSF-1: Gene structure and alternative splicing of mRNA precursors. EMBO J 1987; 6: 2693-2698.
19. Langermans JM, Hulst MEB, Nibbering PH, Furth R. Endogenous tumor necrosis factor alpha is required for enhanced antimicrobial activity against Toxoplasma gondii and Listeria monocytogenes in recombinant gamma interferon-treated mice. Infect Immun 1992; 60: 5107-5112.
20. Lee MT, Warren K. CSF-1-induced resistance to viral infection in murine macrophages. J Immunol 1987; 138: 3019-3022.
21. Liu Z, Simpson RJ, Cheers C. Recombinant interleukin-6 protects mice against experimental bacterial infection. Infect Immun 1992; 60: 4402-4406.
22. Lu L, Shen R-N, Lin Z-H, Aukerman SL, Ralph P, Broxmeyer HE. Anti-tumor effects of recombinant human macrophage colony-stimulating factor, alone or in combination with local irradiation, in mice inoculated with Lewis lung carcinoma cells. Int J Cancer 1991; 47: 143-147.
23. Malefyt RW, Abrams J, Bennett B, Figdor CG, Vries JE. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: An autoregulatory role of IL-10 produced by monocytes. J Exp Med 1991; 174: 1209-1220.
24. Maniatis T, Fritsch EF, Sambrook J. Media and antibiotics. In: Molecular Cloning. New York: Cold Spring Harbor Laboratory, 1982; 68.
25. Metcalf D. The florey lecture, 1991. The colony-stimulating factors: Discovery to clinical use. Philos Trans R Soc Lond B 1991; 333: 147-173.
26. Moore RN, Pitruzzello FJ, Larsen HS, Rouse BT. Feedback regulation of colony-stimulating factor (CSF-1)-induced macrophage proliferation by endogenous E prostaglandins and interferon-α/β, 1984.
27. Motoyoshi K, Suda T, Kusumoto K, Takaku F, Miura Y. Granulocyte-macrophage colony-stimulating and binding activities of purified human urinary colony-stimulating factor to murine and human bone marrow cells. Blood 1982; 60: 1378-1386.
28. Mufson RA, Aghajanian J, Wong G, Woodhouse C, Morgan A. Macrophage colony-stimulating factor enhances monocyte and macrophage antibody-dependent cell-mediated cytotoxicity. Cell Immunol 1989; 119: 182-192.
29. Newman SL, Gootee L. Colony-stimulating factors activate human macrophages to inhibit intracellular growth of Histoplasma capsulatum yeasts. Infect Immun 1992; 60: 4593-4597.
30. Roll JT, Young KM, Kurtz RS, Czuprynski CJ. Human rTNF-α augments anti-bacterial resistance in mice: Potentiation of its effects by recombinant human rIL-1 α. Immunology 1990; 69: 316-322.
31. Sakurai T, Suzu S, Yamada M, Yanai N, Kawashima T, Hatake K, Takaku F, Motoyoshi K. Induction of tumor necrosis factor in mice by recombinant human macrophage colony-stimulating factor. Jpn J Cancer Res 1994; 85: 80-85.
32. Sampson-Johannes A, Carlino JA. Enhancement of human monocyte tumoricidal activity by recombinant M-CSF. J Immunol 1988; 141: 3680-3686.
33. Shadle PJ, Aldwin L, Nitecki DE, Koths K. Human macrophage colony-stimulating factor heterogeneity results from alternative mRNA splicing, differential glycosylation, and proteolytic processing. J Cell Biochem 1989; 40: 91-107.
34. Sherr CJ, Rettenmier CW, Sacca R, Roussel MF, Look AT, Stanley ER. The c-fms proto-oncogene product is related to the receptor for the mononuclear phagocyte growth factor, CSF-1. Cell 1985; 41: 665-676.
35. Thomassen MJ, Barna BP, Wiedemann HP, Ahmad M. Modulation of human alveolar macrophage tumoricidal activity by recombinant macrophage colony-stimulating factor. J Biol Response Modif 1990; 9: 87-91.
36. Vogel SN, Friedman RM. Interferon and macrophages: Activation and cell surface changes. In: J Vilcek and E De Maeyer, Eds. Interferon and the Immune System. Amsterdam: Elsevier, 1984; 35.
37. Warren KM, Ralph P. Macrophage growth factor CSF-1 stimulates human monocyte production of interferon, tumor necrosis factor, and colony stimulating activity. J Immunol 1986; 137: 2281-2285.
38. Wherry JC, Schreiber RD, Unaue ER. Regulation of gamma interferon production by natural killer cells in seid mice: Roles of tumor necrosis factor and bacterial stimuli. Infect Immun 1991; 59: 1709-1715.
39. Wong GG, Temple PA, Leary AC. Human CSF-1: Molecular cloning and expression of 4kb cDNA encoding the human urinary protein. Science 1987; 235: 1504-1508.
40. Zanetti G, Heumann D, Gerain J, Kohler J, Abbet P, Barras C, Lucas R, Glauser M-P, Baumgartner J-D. Cytokine production after intravenous or peritoneal Gram-negative bacterial challenge in mice. J Immunol 1992; 148: 1890-1897.
41. Zhu D, Zhang H, Gao N, Tao X, Han K, Shing Y. Induction of tumor necrosis factor by macrophage colony-stimulating factor in vivo. J Biol Response Mod 1990; 9: 339-342.